Papalocal
Loading…
Papalocal · Things
Company

BioNTech

BioNTech is a Biotechnology company from Germany. It was founded in 2008 by Özlem Türeci and Uğur Şahin. Its headquarters are in Mainz. Its chief executive is Uğur Şahin. It has 1,300 employees (2019).

Founded
June 2008
Founded by
Özlem Türeci
Headquarters
Mainz
Industry
pharmaceutical industry
Chief executive
Uğur Şahin (2008–)
Employees
1,300 (2019)
All 14 facts, and where they come from

Facts

14 facts · 0 confirmed by two sources · 8 cited · 6 from one source

What it is
business Cited
enterprise One source
public company One source
Country of origin
Germany One source
Founded
June 2008 Cited
Founded by
Özlem Türeci One source
Uğur Şahin One source
Headquarters
Mainz One source
Country
Germany Cited
Industry
pharmaceutical industry Cited
Chief executive
Uğur Şahin (2008–) Cited
Employees
1,300 (2019) Cited
Owned by
AT Impf (2020) Cited
Official website
https://biontech.de/ Cited

Where this comes from

Papalocal keeps its own record. It started from these sources; what each one said is kept here as it was copied, so a change on their side never changes this page by itself. Tap one to read its version.

What Wikidata says · copied November 16, 2026 · revision 2534564423
Described as
Biotechnology company from Germany
Other names
Biopharmaceutical New Technologies, Biontech, BioNTech SE, BioNTech AG, BNT, BNTX, BionTech
What it is
business · 1 reference; enterprise; public company
Country of origin
Germany
Founded
June 2008 · 1 reference
Founded by
Özlem Türeci; Uğur Şahin
Headquarters
Mainz · 1 reference
Country
Germany · 3 references
Industry
pharmaceutical industry · 1 reference
Chief executive
Uğur Şahin (2008–) · 1 reference
Employees
1,300 (2019) · 1 reference
Owned by
AT Impf (2020) · 1 reference
Official website
https://biontech.de/ · 1 reference
Wikipedias with a page
45

Wikidata item Q30256699 (wikidata.org/wiki/Q30256699), public domain (CC0). Copied 2026-11-16.

What Wikipedia says · copied November 16, 2026 · revision 1376511113

BioNTech SE ( bee-ON-tek; or bye-ON-tek short for Biopharmaceutical New Technologies) is a German multinational biotechnology company headquartered in Mainz that develops immunotherapies and vaccines, particularly for cancer and infectious diseases.
The company utilizes technology platforms including mRNA-based therapies, targeted therapies, and immunomodulators, to develop its treatments. BioNTech's pipeline includes several late-stage programs in oncology testing combination therapy approaches to improve treatment outcomes.
In the field of infectious diseases, BioNTech, partnering with Pfizer, developed Comirnaty, the first approved mRNA-based vaccine, which was widely used during the COVID-19 pandemic.

From the Wikipedia article “BioNTech” (en.wikipedia.org/wiki/BioNTech), by its contributors, under CC BY-SA 4.0 (creativecommons.org/licenses/by-sa/4.0/). Copied 2026-11-16; not changed.

Confirmed Two sources agree. Cited One source, and it names where it got it. One source One source, without a reference of its own. Sources disagree The sources disagree. We show the best-supported value and keep theirs below.

Picture: Wikimedia Commons: Mainz.BioNTechSE.20200731.jpg · See Commons file page

People connected 1

Worked here